On August 30, Huawei and RuiJin Hospital officially released RuiPath 2.0, the Ruizhi Pathology Model, and officially licensed RuiPath 2.0, which landed in 90+ hospitals across the country. According to reports, RuiPath 2.0, the large pathological model RuiPath 2.0 has significantly improved the ability to recognize common cancer types and rare subtypes, and is exploring the application of the pathological multi-modal generative basic model in lymphoma diagnosis.

On August 30, Huawei and RuiJin Hospital officially released RuiPath 2.0, the Ruizhi Pathology Model, and officially licensed RuiPath 2.0, which landed in 90+ hospitals across the country. According to reports, RuiPath 2.0, the large pathological model RuiPath 2.0 has significantly improved the ability to recognize common cancer types and rare subtypes, and is exploring the application of the pathological multi-modal generative basic model in lymphoma diagnosis.